Albayrak M - Search Results

1

Ibrutinib-induced polyneuropathy: A case report.

Cömert P, Albayrak M, Yıldız A, Şahin O, Öztürk HB, Reis Aras M. Cömert P, et al. Among authors: albayrak m. J Oncol Pharm Pract. 2020 Sep;26(6):1501-1504. doi: 10.1177/1078155220903357. Epub 2020 Feb 6. J Oncol Pharm Pract. 2020. PMID: 32028841

2

The rare coexistence of high titer inhibitor development and gastrointestinal stromal tumor in a patient with severe hemophilia: A case report.

Yıldız A, Şahin O, Yayar O, Öztürk ÇP, Afacan Öztürk HB, Maral S, Okutan H, Albayrak M. Yıldız A, et al. Among authors: albayrak m. Transfus Apher Sci. 2018 Jun;57(3):398-400. doi: 10.1016/j.transci.2018.04.023. Epub 2018 Apr 26. Transfus Apher Sci. 2018. PMID: 29724628

3

Dimethyl Sulfoxide-Induced Tonic-Clonic Seizure and Cardiac Arrest During Infusion of Autologous Peripheral Blood Stem Cells.

Maral S, Albayrak M, Pala C, Yildiz A, Sahin O, Ozturk HB. Maral S, et al. Among authors: albayrak m. Cell Tissue Bank. 2018 Dec;19(4):831-832. doi: 10.1007/s10561-018-9718-x. Epub 2018 Aug 11. Cell Tissue Bank. 2018. PMID: 30099684

4

Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience.

Yıldız A, Öztürk HB, Albayrak M, Pala Ç, Şahin O, Maral S, Okutan H. Yıldız A, et al. Among authors: albayrak m. J Oncol Pharm Pract. 2019 Sep;25(6):1381-1387. doi: 10.1177/1078155218795323. Epub 2018 Aug 22. J Oncol Pharm Pract. 2019. PMID: 30134766

5

The efficacy of double filtration plasmapheresis in the treatment of homozygous familial hypercholesterolemia: A single-center experience.

Albayrak M, Yıldız A, Ateş N, Pala Ç. Albayrak M, et al. Transfus Apher Sci. 2019 Feb;58(1):61-64. doi: 10.1016/j.transci.2018.11.007. Epub 2018 Dec 5. Transfus Apher Sci. 2019. PMID: 30545658

6

CD81 Expression in the Differential Diagnosis of Chronic Lymphocytic Leukemia.

Afacan-Öztürk HB, Falay M, Albayrak M, Yıldız A, Öztürk ҪP, Maral S, Özet G. Afacan-Öztürk HB, et al. Among authors: albayrak m. Clin Lab. 2019 Mar 1;65(3). doi: 10.7754/Clin.Lab.2018.180802. Clin Lab. 2019. PMID: 30868852

7

A first time report on the coocurrence of sarcoidosis and ALK(-) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment.

Afacan Öztürk HB, Albayrak M, Pala Öztürk Ç, Yıldız A, Maral S, Önder E. Afacan Öztürk HB, et al. Among authors: albayrak m. J Oncol Pharm Pract. 2019 Oct;25(7):1801-1805. doi: 10.1177/1078155219837331. Epub 2019 Mar 25. J Oncol Pharm Pract. 2019. PMID: 30909793

8

Refractory Thrombotic Thrombocytopenic Purpura in a patient with Kaposi sarcoma.

Sahin O, Albayrak M, Yıldız A, Pala Ç, Aktas L, Maral S, Afacan Öztürk HB, Cömert P. Sahin O, et al. Among authors: albayrak m. Transfus Apher Sci. 2019 Apr;58(2):187-189. doi: 10.1016/j.transci.2019.02.003. Epub 2019 Mar 19. Transfus Apher Sci. 2019. PMID: 30910619

9

An acute transverse myelitis attack after autologous stem cell transplantation: A rare case.

Cömert P, Albayrak M, Yıldız A, Şahin O, Öztürk ÇP, Maral S, Güneş G, Afacan Öztürk HB, Sağlam B. Cömert P, et al. Among authors: albayrak m. Transfus Apher Sci. 2019 Jun;58(3):341-343. doi: 10.1016/j.transci.2019.05.002. Epub 2019 May 14. Transfus Apher Sci. 2019. PMID: 31113744

10

The incidence and risk factors of thrombosis and the need for thromboprophylaxis in lymphoma and leukemia patients: A 9-year single-center experience.

Yıldız A, Albayrak M, Pala Ç, Afacan Öztürk HB, Maral S, Şahin O, Cömert P. Yıldız A, et al. Among authors: albayrak m. J Oncol Pharm Pract. 2020 Mar;26(2):386-396. doi: 10.1177/1078155219851540. Epub 2019 Jun 2. J Oncol Pharm Pract. 2020. PMID: 31156054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters